PMC:7696151 / 56023-56231 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"1619","span":{"begin":49,"end":52},"obj":"Chemical"},{"id":"1620","span":{"begin":112,"end":115},"obj":"Chemical"},{"id":"1621","span":{"begin":151,"end":158},"obj":"Chemical"},{"id":"1622","span":{"begin":163,"end":170},"obj":"Chemical"},{"id":"1633","span":{"begin":0,"end":22},"obj":"Disease"}],"attributes":[{"id":"A1619","pred":"tao:has_database_id","subj":"1619","obj":"MESH:D006886"},{"id":"A1620","pred":"tao:has_database_id","subj":"1620","obj":"MESH:D006886"},{"id":"A1621","pred":"tao:has_database_id","subj":"1621","obj":"MESH:D001241"},{"id":"A1622","pred":"tao:has_database_id","subj":"1622","obj":"MESH:D006493"},{"id":"A1633","pred":"tao:has_database_id","subj":"1633","obj":"MESH:D054556"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"venous thromboembolism confirmed the efficacy of HCQ also in clinical practice. The addition of 400 mg daily of HCQ to a common therapeutic regimen of aspirin and heparin dramatically reduced the episodes of "}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T98","span":{"begin":7,"end":22},"obj":"Phenotype"}],"attributes":[{"id":"A98","pred":"hp_id","subj":"T98","obj":"http://purl.obolibrary.org/obo/HP_0001907"}],"text":"venous thromboembolism confirmed the efficacy of HCQ also in clinical practice. The addition of 400 mg daily of HCQ to a common therapeutic regimen of aspirin and heparin dramatically reduced the episodes of "}